Tetany, Hypomagnesemia, and Proton-pump Inhibitors Giuseppe Famularo, MD, PhD, Giovanni Minisola, MD, Maria Cristina Bravi, MD, PhD, Pasquale Colucci, MD, Laura Gasbarrone, MD The American Journal of Medicine Volume 125, Issue 10, Pages e7-e8 (October 2012) DOI: 10.1016/j.amjmed.2012.04.027 Copyright © 2012 Elsevier Inc. Terms and Conditions
Figure Changes in serum magnesium (Top) and serum PTH (Bottom) levels during treatment with proton-pump inhibitors (see text for details). Shaded areas represent the normal range. PTH=parathyroid hormone. The American Journal of Medicine 2012 125, e7-e8DOI: (10.1016/j.amjmed.2012.04.027) Copyright © 2012 Elsevier Inc. Terms and Conditions